Meridian Clinical Research has acquired Regional Clinical Research, expanding its North American footprint to more than 20 investigative sites. Meridian now supports more than 60 principal investigators. The acquisition also increases Meridian's existing therapeutic expertise in infectious diseases, neurology, and women's health.
Regional was established in 1993 and operates four research sites in the southern tier of New York. Meridian and Regional are longtime members of Platinum Research Network. The acquisition enhances Meridian's existing therapeutic expertise in infectious diseases, neurology, and women's health.
"This is a perfect addition," said Nicole Osborn, founder and CEO of Meridian. "We've known Regional's leaders and collaborated on best practices for years. Their team shares our mentality and our sense of purpose for patient-centric research."
Meridian is strategically aligned with seven top-10 sponsors and eight top-10 contract research organizations (CROs) - Osborn said the company's acquisition of Regional is a response to client requests to expand relationships. "This strengthens our therapeutic depth in the right areas and gives us room to scale naturally," she said.
"This is a positive step for both companies, our partners, and our clients," said Debra Gabrielson, CEO of Regional and new Vice President at Meridian. "We're aligned with Meridian in many ways and we're eager to leverage its unique resources and programs."
Dr. Bowling and Dr. Elinoff, who shared ownership of Regional, also expressed their satisfaction with the acquisition. "Through almost 30 years we carefully shaped a company that advanced medicine in a uniquely compassionate way. We established a team and legacy we're proud of, and now more than ever, we know Regional is positioned to thrive as part of Meridian."
In addition to three other sites, Regional has also partnered with United Health Services Hospitals since 2002 to conduct outpatient research and has a total of 10 principal investigators. Meridian, which is celebrating its twentieth year in business, now supports more than 60 principal investigators.
"Regional's management team and all of its employees will join the Meridian family, and we look forward to achieving more than ever together," said Osborn.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.